FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to gynecology, and can be used to treat HPV-associated cervical grade I neoplasias. To do this, the cervix is applied to the cervix with a cavitation solution of panavir, administered intravaginally at a dose of 5.0 ml, diluted in 50 ml of saline. Effect is carried out once a day for 5 days. Control of healing is carried out at the end of therapy, then after 30 days. HPV test after 60 days.
EFFECT: method provides a complex, rapid and reliable effect aimed at eliminating the human papillomavirus, and as a result, acceleration of reparative processes on the cervix, prevention of recurrence of the process of intraepithelial neoplasia.
1 cl, 2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING HPV-ASSOCIATED CERVICAL I DEGREE NEOPLASIAS WITH APPLICATION OF CAVITATED IMUNOFAN SOLUTION | 2013 |
|
RU2565846C2 |
| METHOD OF TREATING HPV ASSOCIATED CERVICAL NEOPLASIAS II-III DEGREE | 2015 |
|
RU2585423C1 |
| METHOD FOR PREDICTING THE RISK OF PROGRESSION OF RECURRENT CERVICAL INTRAEPITHELIAL NEOPLASIAS OF LOW DEGREE OF ONCOGENIC RISK ASSOCIATED WITH HUMAN PAPILLOMAVIRUS INFECTION | 2020 |
|
RU2748719C1 |
| METHOD OF TREATING CERVICITIS ASSOCIATED WITH HUMAN PAPILLOMA VIRUS | 2018 |
|
RU2688326C1 |
| PREDICTION METHOD OF HPV-ASSOCIATED CERVICAL INTRAEPITHELIAL NEOPLASIA DEVELOPMENT | 2016 |
|
RU2621294C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF THE CONDUCTED TREATMENT OF I-II DEGREE CERVICAL INTRAEPITHELIAL NEOPLASIAS | 2021 |
|
RU2773799C1 |
| METHOD OF REHABILITATION AFTER DESTRUCTIVE METHODS OF THERAPY IN CASE OF CERVICAL DISEASES, ASSOCIATED WITH PAPILLOMAVIRUS INFECTION | 2012 |
|
RU2480202C1 |
| METHOD OF TREATING UROGENITAL CANDIDIASIS USING ULTRASONIC CAVITATION AND PHOTOCHROMOTHERAPY | 2019 |
|
RU2704470C1 |
| METHOD FOR PREVENTION OF HPV-ASSOCIATED RECURRENCES OF CIN II-III AND CC 1A1 ST | 2020 |
|
RU2737051C2 |
| METHOD FOR DYNAMIC CONTROL OF EFFICIENCY OF TREATMENT OF CERVICAL INTRAEPITHELIAL LESIONS OF CERVIX UTERI BY MEANS OF DIINDOLYLMETHANE-BASED SUPPOSITORIES | 2015 |
|
RU2618427C1 |
